tetraphenylphosphonium has been researched along with bay-k-8644 in 2 studies
Studies (tetraphenylphosphonium) | Trials (tetraphenylphosphonium) | Recent Studies (post-2010) (tetraphenylphosphonium) | Studies (bay-k-8644) | Trials (bay-k-8644) | Recent Studies (post-2010) (bay-k-8644) |
---|---|---|---|---|---|
438 | 0 | 39 | 2,555 | 0 | 144 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carpenter, CL; Greenberg, DA; Messing, RO | 1 |
Fox, RM; Markham, A; Morgan, RM | 1 |
2 other study(ies) available for tetraphenylphosphonium and bay-k-8644
Article | Year |
---|---|
Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium; Calcium Channel Blockers; Cells, Cultured; Isradipine; Kinetics; Membrane Potentials; Nifedipine; Nitrendipine; Onium Compounds; Organophosphorus Compounds; Oxadiazoles; Potassium; Pyridines; Tritium | 1986 |
Calcium antagonists and Bay K8644 promote depolarization of the rat heart mitochondrial membrane potential. Further evidence for a role in alteration of oxidative metabolism.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Biological Transport, Active; Calcium; Calcium Channel Blockers; Electrodes; Intracellular Membranes; Male; Membrane Potentials; Mitochondria, Heart; Onium Compounds; Organophosphorus Compounds; Oxidation-Reduction; Oxidative Phosphorylation; Rats; Rats, Wistar | 1993 |